(19)
(11) EP 1 765 287 A2

(12)

(43) Date of publication:
28.03.2007 Bulletin 2007/13

(21) Application number: 05857458.3

(22) Date of filing: 16.06.2005
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
(86) International application number:
PCT/US2005/021284
(87) International publication number:
WO 2006/096194 (14.09.2006 Gazette 2006/37)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL BA HR LV MK YU

(30) Priority: 17.06.2004 US 581244 P

(71) Applicant: Merz Pharma GmbH & Co. KGaA
60318 Frankfurt Main (DE)

(72) Inventors:
  • YANG, Yan
    Roslyn Heights, New York 11577 (US)
  • JANJIKHEL, Ragiv
    Bridgewater, NJ 08807 (US)
  • RAO, Niranjan
    Belle Mead, NJ 08502 (US)
  • PERICLOU, Antonio
    New Jersey, New Jersey 07310 (US)
  • ABRAMOWITZ, Wattanaporn
    West Windsor, NJ 08550 (US)
  • DEDIHIYA, Mahendra, G.
    Pomona, New York 10970 (US)
  • SEILLER, Erhard
    61130 Nidderau (DE)
  • HAUPTMEIER, Bernhard
    63571 Geinhausen (DE)

(74) Representative: Marsden, John Christopher 
Frank B. Dehn & Co. St Bride's House 10 Salisbury Square
London EC4Y 8JD
London EC4Y 8JD (GB)

   


(54) IMMEDIATE RELEASE FORMULATIONS OF MEMANTINE ORAL DOSAGE FORMS